| Application no. and date | 18730518.0 (espacenet) (Federated) (European Patent Register), 20180515 | | Patent/reg. no. and date | DK/EP 3624837, 20250730 | | Publication date | 20200325 | | Priority no. and date | US 201762507053 P, 20170516, US 201762581992 P, 20171106 | | EP pub. no. and date |
EP 3624837 20200325 | | Effective date | | | Applicant/owner | Five Prime Therapeutics, Inc., 111 Oyster Point Boulevard
South San Francisco, CA 94080, US | | Applicant ref. no. | 2024447 | | Inventor | COLLINS, Helen L., 111 Oyster Point Boulevard
South San Francisco
California 94080, US,
HNATYSZYN, James, 111 Oyster Point Boulevard
South San Francisco
California 94080, US,
XIANG, Hong, 111 Oyster Point Boulevard
South San Francisco
California 94080, US,
ZHANG, Xiang, 111 Oyster Point Boulevard
South San Francisco
California 94080, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/22 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTI-FGFR2-ANTISTOFFER I KOMBINATION MED KEMOTERAPEUTISKE MIDLER TIL KRÆFTBEHANDLING | | Int. application no. | US2018032757 | | Int. publication no. | WO2018213304 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
